ArticleWorld journal of microbiology & biotechnology2023
Seed biopriming with potential bioagents influences physiological processes and plant defense enzymes to ameliorate sheath blight induced yield loss in rice (Oryza sativa L.).
Article in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 16 citations in OpenAlex.
- Exploiting the potential of microbial consortia against sheath blight in basmati rice caused by Rhizoctonia solani.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Pathogen-mediated priming induces intergenerational immunity against spot blotch in wheat.World journal of microbiology & biotechnology · 2026Article
- Endophytic Bacillus velezensis BDKishJoy 6B promotes rice growth and enhances resistance to Magnaporthe oryzae.Scientific reports · 2025Article
- Emerging progress in investigating the impact of green-synthesized nanoparticles on seed germination.Journal of plant research · 2025Review
- Antioxidant Responses and Redox Regulation Within Plant-Beneficial Microbe Interaction.Antioxidants (Basel, Switzerland) · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disease management with the use of conventional pesticides has emerged as a major threat to the environment and human health. Moreover, the increasing cost of pesticides and their use in staple crops such as rice is not economically sustainable. The present study utilized a combination of two commercial powder formulations of biocontrol agents, Trichoderma harzianum (Th38) and Pseudomonas fluorescens (Pf28) to induce resistance against sheath blight disease via seed biopriming in basmati rice variety Vasumati and compared the performance with systemic fungicide carbendazim. Sheath blight infection significantly increased the levels of stress indicators such as proline (0.8 to 4.25 folds), hydrogen peroxide (0.89 to 1.61 folds), and lipid peroxidation (2.4 to 2.6 folds) in the infected tissues as compared to the healthy control. On the contrary, biopriming with biocontrol formulation (BCF) significantly reduced the level of stress markers, and substantially enhanced the levels of defense enzymes such as peroxidase (1.04 to 1.18 folds), phenylalanine ammonia lyase (1.02 to 1.17 folds), lipoxygenase (1.2 to 1.6 folds), and total phenolics (74% to 83%) as compared to the infected control. Besides, improved photosynthesis (48% to 59%) and nitrate reductase activity (21% to 42%) showed a positive effect on yield and biomass, which compensated disease induced losses in bio-primed plants. Conversely, the comparative analysis of the efficacy levels of BCF with carbendazim revealed BCF as a potential and eco-friendly alternative for reducing disease impact and maintaining higher yield in rice under sheath blight infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.